Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7443 p300
17 March 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Alliance launched in Scotland to improve patient safety in hospitals

A new patient safety programme called the Scottish Patient Safety Alliance was launched this week.

The alliance aims to reduce harm to patients by tackling issues like prescribing errors and preventable infections. It will do this first by identifying good practice and then ensuring that standards of good practice are applied consistently in all hospitals in Scotland. Examples of processes the alliance will target include systems to ensure patients receive the right medicine at the right time and in the right dose, and monitoring systems to identify patients whose health is deteriorating quickly. The alliance’s five objectives are to:

• Reduce health care-associated infection
• Reduce adverse surgical incidents
• Reduce adverse drug events
• Improve critical care outcomes
• Improve organisational and leadership culture on safety

The alliance builds on the Safer Patients Initiative which has been piloted at various hospitals across the UK. In Scotland, this work has been led by NHS Tayside, where adverse events have been cut by more than half and the number of prescriptions requiring amendments has been reduced from 70 per cent to 2.6 per cent.

One of the pharmacists involved in the NHS Tayside programme is Gordon Thomson, principal clinical medicine and cardiovascular pharmacist, at Ninewells Hospital, Dundee. He commented: “The alliance will provide an exciting opportunity for hospital pharmacy staff in all Scottish hospitals to play a lead role in further improving medicines safety over the next five years. It will use new methods to test, implement and measure improvements in areas such as medicines reconciliation and the use of high risk medicines (like anticoagulants, opiates and insulin) as part of an evidence-based package of changes designed to improve patient safety.”

Back to Top


©The Pharmaceutical Journal